OC-0130: Biomarker-based hypoxia-adapted radiochemotherapy: preclinical study in HPV+/- H&N cancer xenografts. (April 2016) - Koi, L.; Moebius, L.; Weise, C.; Erdmann, C.; Valentini, C.; Schmidt, M.; Krause, M.; Baumann, M.